Massachusetts Financial Services CO Ascendis Pharma A/S Transaction History

Massachusetts Financial Services CO

$282 Billion
Q1 2025

A detailed history of Massachusetts Financial Services CO transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Massachusetts Financial Services CO holds 1,877,917 shares of ASND stock, worth $311 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

1,877,917

Previous 1,867,551 0.56%

Holding current value

$311 Million

Previous $257 Million 13.84%

% of portfolio

0.1%

Previous 0.09%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 02, 2025	BUY	$119.49 - $168.84 $1.24 Million - $1.75 Million	10,366 Added 0.56%	1,877,917 $293 Million
Q4 2024 Feb 12, 2025	BUY	$122.0 - $146.6 $68,930 - $82,829	565 Added 0.03%	1,867,551 $257 Million
Q3 2024 Nov 12, 2024	BUY	$113.0 - $153.43 $17.6 Million - $23.9 Million	155,971 Added 9.12%	1,866,986 $279 Million
Q2 2024 Aug 09, 2024	BUY	$121.07 - $153.67 $11.3 Million - $14.3 Million	93,185 Added 5.76%	1,711,015 $233 Million
Q1 2024 May 14, 2024	BUY	$123.45 - $159.4 $12.2 Million - $15.7 Million	98,611 Added 6.49%	1,617,830 $245 Million
Q4 2023 Feb 08, 2024	BUY	$86.1 - $127.36 $21.9 Million - $32.4 Million	254,749 Added 20.15%	1,519,219 $191 Million
Q3 2023 Nov 08, 2023	BUY	$86.5 - $103.97 $15.3 Million - $18.4 Million	176,948 Added 16.27%	1,264,470 $118 Million
Q2 2023 Aug 09, 2023	SELL	$69.96 - $97.84 $18.9 Million - $26.4 Million	-270,052 Reduced 19.89%	1,087,522 $97.1 Million
Q1 2023 May 10, 2023	BUY	$104.9 - $126.78 $1.47 Million - $1.77 Million	13,972 Added 1.04%	1,357,574 $146 Million
Q4 2022 Feb 13, 2023	BUY	$99.42 - $131.97 $15.8 Million - $21 Million	159,246 Added 13.45%	1,343,602 $164 Million
Q3 2022 Nov 09, 2022	BUY	$84.03 - $110.23 $29.3 Million - $38.5 Million	349,157 Added 41.81%	1,184,356 $122 Million
Q2 2022 Aug 09, 2022	BUY	$78.08 - $117.61 $5.02 Million - $7.56 Million	64,270 Added 8.34%	835,199 $77.6 Million
Q1 2022 May 11, 2022	BUY	$102.18 - $135.75 $1.9 Million - $2.53 Million	18,627 Added 2.48%	770,929 $90.5 Million
Q4 2021 Feb 10, 2022	BUY	$127.1 - $169.66 $1.06 Million - $1.41 Million	8,323 Added 1.12%	752,302 $101 Million
Q3 2021 Nov 10, 2021	BUY	$112.67 - $176.92 $4.91 Million - $7.7 Million	43,541 Added 6.22%	743,979 $119 Million
Q2 2021 Aug 13, 2021	SELL	$121.62 - $145.29 $1.29 Million - $1.54 Million	-10,607 Reduced 1.49%	700,438 $92.1 Million
Q1 2021 May 13, 2021	BUY	$124.92 - $173.33 $1.51 Million - $2.1 Million	12,104 Added 1.73%	711,045 $91.6 Million
Q4 2020 Feb 12, 2021	BUY	$151.2 - $182.76 $5.02 Million - $6.06 Million	33,184 Added 4.98%	698,941 $117 Million
Q3 2020 Nov 12, 2020	BUY	$134.29 - $154.32 $89.4 Million - $103 Million	665,757 New	665,757 $103 Million

Others Institutions Holding ASND

# of Institutions

272

Shares Held

61.8M

Call Options Held

151K

Put Options Held

226K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $9.24B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account

Massachusetts Financial Services CO Ascendis Pharma A/S Transaction History